Probiotix HealthFRA:X90 -0.68% Gross Margin % is 52.87% as of Dec. 2025, which is 3% below its 10-year median of 54.25. The stock has 1 warning sign investors should review. Among 734 Biotechnology companies, Probiotix Health ranks worse than 55.86% on this metric.
The historical rank and industry rank for Probiotix Health's Gross Margin % or its related term are showing as below:
FRA:X90'
s Gross Margin % Range Over the Past 10 Years
Min: 52.12 Med: 54.25 Max: 72.61
Current: 54.25
During the past 7 years, the highestGross Margin % of Probiotix Health was 72.61%. The lowest was 52.12%. And the median was 54.25%.
FRA:X90's Gross Margin % is ranked worse than 55.86% of 734
companies
in the Biotechnology industry
Industry Median: 60.795
vs FRA:X90: 54.25
Probiotix Health had a gross margin of 52.87% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Probiotix Health was 0.00% per year.
Probiotix Health (FRA:X90) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Probiotix Health had a gross margin of 52.87% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Probiotix Health Gross Margin % Related Terms
Probiotix Health Gross Margin % Historical Data
* Premium members only.
The historical data trend for Probiotix Health's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:X90 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Probiotix Health's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Probiotix Health Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Probiotix Health's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Probiotix Health's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Probiotix Health (FRA:X90) has a Gross Margin % of 52.87% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Probiotix Health and its competitors. This is near median its historical median of 54.25. Over the past decade, Probiotix Health's Gross Margin % has ranged from 52.12 to 72.61. According to the industry distribution chart, Probiotix Health ranks #410 out of 734 companies in the Biotechnology industry, placing it in the top 55.9%.
Is Probiotix Health's Gross Margin % too high?
Probiotix Health's current Gross Margin % of 52.87% is near median its 10-year median of 54.25. Over the past 10 years, this metric has ranged from a low of 52.12 to a high of 72.61. The Biotechnology industry median Gross Margin % is 60.80. Probiotix Health's value of 52.87% is 13% below this industry median. Based on the distribution chart, Probiotix Health ranks #410 out of 734 companies in the Biotechnology industry, which is below the industry midpoint.
How does Probiotix Health's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Probiotix Health ranks #410 out of 734 companies for Gross Margin %. This places Probiotix Health in the lower half of its industry. The industry median Gross Margin % is 60.80. Probiotix Health's value of 52.87% is 13% below this benchmark. Historically, Probiotix Health's own Gross Margin % has ranged from 52.12 to 72.61 over the past decade. While the company's 10-year median is 54.25 vs. the industry median of 60.80, Probiotix Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.80, based on 734 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Probiotix Health's current Gross Margin % of 52.87% is 13% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Probiotix Health and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Probiotix Health's current Gross Margin % is 52.87%, which is near median its own 10-year median of 54.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Probiotix Health stock overvalued right now?
Probiotix Health (FRA:X90) has a current Gross Margin % of 52.87%. The stock's GF Value™ is €0.09, compared to a current price of €0.07 — trading 18.3% below its estimated fair value. The current Gross Margin % is 52.87%, which is near median its 10-year median of 54.25 and 13% below the Biotechnology industry median of 60.80. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Probiotix Health (FRA:X90), the current Gross Margin % is 52.87% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Probiotix Health PLC is a life sciences company that develops probiotics to tackle cardiovascular disease and other lifestyle conditions that are affecting growing numbers of people across the world. The company has one class of business, in three geographical areas, being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry. Its geographical segments include the United Kingdom, the United States, and the Rest of the World. It generates the majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:X90 has been successfully added to your 